The results show that sunitinib has the potential to inhibit NSCLC cell proliferation and TGF-β1-induced EMT through Smad/non-Smad signaling and TNIK-mediated Wnt signaling. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.